About 84 results
Open links in new tab
  1. Rigel Pharmaceuticals, Inc. (RIGL)

    Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer.

  2. Rigel Provides Business Update and 2026 Outlook

    6 days ago · Enrollment in the dose expansion phase of the Phase 1b study is ongoing and Rigel is on track to complete enrollment and select the recommended Phase 2 dose for future clinical studies in …

  3. Pipeline :: Rigel Pharmaceuticals, Inc. (RIGL)

    Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and …

  4. Products :: Rigel Pharmaceuticals, Inc. (RIGL)

    Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and …

  5. Investor Relations :: Rigel Pharmaceuticals, Inc. (RIGL)

    Dec 7, 2025 · Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel, small molecule drugs that significantly improve the lives of patients with immune …

  6. Management Team :: Rigel Pharmaceuticals, Inc. (RIGL)

    Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and …

  7. Who We Are :: Rigel Pharmaceuticals, Inc. (RIGL)

    Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and …

  8. Rigel Provides Business Update and 2025 Outlook

    Jan 13, 2025 · Rigel continues to advance its Phase 1b clinical study evaluating the safety, tolerability, pharmacokinetics, and preliminary efficacy of R289 in patients with relapsed or refractory (R/R) lower …

  9. Join Our Team :: Rigel Pharmaceuticals, Inc. (RIGL)

    Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and …

  10. SEC Filings :: Rigel Pharmaceuticals, Inc. (RIGL)

    Nov 4, 2025 · © 2026 Rigel Pharmaceuticals, Inc. All Rights Reserved. TAVALISSE, TAVLESSE, REZLIDHIA, GAVRETO, RIGEL and the Rigel arc logo are registered trademarks of Rigel …